Chloe Nadia Halim

Wight-loss drugs have the potential to reach US$80 billion in sales by 2030, according to Bloomberg, up from US$6 billion in 2023.
INVESTING GLOBALLY & PROFITABLY

Global healthcare: From laggards to opportunities

The healthcare sector sees an increase in utilisation rates amid massive interest in weight-loss drugs, but it also faces a post-Covid reset

The rise in oil prices amid geopolitical conflict raises fresh fears of a spike in inflation which could weigh on the global economy.
INVESTING GLOBALLY & PROFITABLY

Oil price volatility amid Israel-Hamas war raises inflation fears

Further escalation of conflict could jeopardise crude exports from a region that produces about a third of global supply

The healthcare sector is more defensive, and tends to outperform the broader market. Beyond this, the sector also possesses some growth characteristics, coming from the ability to deliver significant innovation to patients.
INVESTING GLOBALLY & PROFITABLY

A healthy investment: Why putting your money in this sector pays off

With global macroeconomic challenges ahead, the defensive characteristics of the healthcare sector coupled with its growth prospects arising from continued innovation have...

Despite higher prices, capital expenditure in oil and gas continues to decline
INVESTING GLOBALLY & PROFITABLY

Can the commodities sector overcome recession fears?

Multiple factors, including war, underinvestment in supply, record inflation and the energy transition, underpin investment opportunities in commodities

China accounts for a growing share of foreign grain purchases by volume.
INVESTING GLOBALLY & PROFITABLY

Riding on agribusiness opportunities as food demand rises

Despite recessionary fears, food and agriculture remain necessities and prices are likely higher for longer.